Published Jul 31, 2022

Immunai CTO and Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs - Ep. 176

Immunai's CTO Luis Voloch delves into how AI and single-cell genomics are revolutionizing immunotherapy development, spotlighting innovative cross-disciplinary collaborations and ethical considerations in biotech research.

Episode Highlights

Topics covered

Popular Clips

Episode Highlights

Related Episodes

Artem Cherkasov and Olexandr Isayev on Democratizing Drug Discovery with Deep Learning - Ep. 172
Answers 383 questions
Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230
Answers 383 questions
Imbue CEO Kanjun Qiu on Transforming AI Agents Into Personal Collaborators - Ep. 239
Answers 383 questions
Bojan Tunguz, Johnny Israeli on How AI and Crowdsourcing Can Advance Vaccine Distribution - Ep. 195
Answers 383 questions
Ep. 40: Using Deep Learning to Scan Your Shopping Basket
Answers 383 questions
Startup Uses Deep Learning to Understand Voice - Ep. 66
Answers 383 questions
Ep. 2: Where Deep Learning Goes Next - Bryan Catanzaro, NVIDIA Applied Deep Learning Research
Answers 383 questions
NVIDIA’s Clément Farabet on Orchestrating AI Training for Autonomous Vehicles - Ep. 175
Answers 383 questions
Doc.ai CEO Walter De Brouwer on How Federated Learning Can Help Keep Data Private- Ep. 94
Answers 383 questions
Nanotronics Brings Deep Learning to Precision Manufacturing - Ep. 109
Answers 383 questions
Ep. 52: Live at GTC - How Deep Learning Can Fight Cancer
Answers 383 questions
A Conversation About Go, Sci-Fi, Deep Learning and Computational Chemistry - Ep. 54
Answers 383 questions
Ep. 3: Deep Learning DIY - NVIDIA Engineer Bob Bond, Make: Magazine Executive Editor Mike Senese
Answers 383 questions
Miracle Qure: Founder Pooja Rao Talks Medical Technology at Qure.ai - Ep. 136
Answers 383 questions
Codeium’s Varun Mohan and Jeff Wang on Unleashing the Power of AI in Software Development - Ep. 200
Answers 383 questions

Dexa/The AI Podcast

Immunai CTO and Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs - Ep. 176

Topics covered

Popular Clips

Data and Ethics

Experimentation and Ethics

Fostering Internal Learning

Data Quality Insights

Hybrid Culture Dynamics

Synthetic Data's Future

Machine Learning in Biotech

Cell Type Classification

Episode Highlights

Immune System Innovations

Hybrid Organizational Culture

Machine Learning Challenges

Ethics and Data

Related Episodes

Artem Cherkasov and Olexandr Isayev on Democratizing Drug Discovery with Deep Learning - Ep. 172

Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230

Imbue CEO Kanjun Qiu on Transforming AI Agents Into Personal Collaborators - Ep. 239

Bojan Tunguz, Johnny Israeli on How AI and Crowdsourcing Can Advance Vaccine Distribution - Ep. 195

Ep. 40: Using Deep Learning to Scan Your Shopping Basket

Startup Uses Deep Learning to Understand Voice - Ep. 66

Ep. 2: Where Deep Learning Goes Next - Bryan Catanzaro, NVIDIA Applied Deep Learning Research

NVIDIA’s Clément Farabet on Orchestrating AI Training for Autonomous Vehicles - Ep. 175

Doc.ai CEO Walter De Brouwer on How Federated Learning Can Help Keep Data Private- Ep. 94

Nanotronics Brings Deep Learning to Precision Manufacturing - Ep. 109

Ep. 52: Live at GTC - How Deep Learning Can Fight Cancer

A Conversation About Go, Sci-Fi, Deep Learning and Computational Chemistry - Ep. 54

Ep. 3: Deep Learning DIY - NVIDIA Engineer Bob Bond, Make: Magazine Executive Editor Mike Senese

Miracle Qure: Founder Pooja Rao Talks Medical Technology at Qure.ai - Ep. 136

Codeium’s Varun Mohan and Jeff Wang on Unleashing the Power of AI in Software Development - Ep. 200

Immunai CTO and Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs - Ep. 176

Topics covered

Popular Clips

Episode Highlights

Immune System InnovationsLuis Voloch, CTO and Co-Founder of Immunai, discusses how AI and single cell genomics are transforming the development of new immunotherapies. He explains the innovative approaches his company uses to map the immune system and identify therapeutic targets.

Immune System Innovations

Hybrid Organizational Culture

Machine Learning ChallengesLuis Voloch explores the critical role of data quality and deep learning frameworks in advancing biological research. He shares insights into the challenges of handling noisy data and the need for specialized algorithms to map the immune system effectively.

Machine Learning Challenges

Ethics and DataThe ethical landscape of animal experimentation in biotech is evolving with advancements in machine learning and synthetic data. Luis Voloch discusses how these technologies could reshape research methodologies and address ethical concerns.

Ethics and Data

Related Episodes